[Current migraine therapy].
D004878:Ergotamine / Q000627:therapeutic use*; D005767:Gastrointestinal Diseases / Q000150:complications; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008784:Methysergide / Q000627:therapeutic use; D008881:Migraine Disorders / Q000188:drug therapy*; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use
D006993:Hypnotics and Sedatives; D008996:Monoamine Oxidase Inhibitors; D014149:Tranquilizing Agents; D004878:Ergotamine; D008784:Methysergide
Aktuelle Migränetherapie.